Overview
Urologic and bladder dysfunction affect approximately 50% of people with Alström Syndrome and tend to emerge in late teens and adulthood, particularly in females.¹ The pattern includes detrusor-urethral dyssynergia and other voiding issues. Recognition and management improve quality of life. This article covers what to look for and treatment approaches.
What "detrusor-urethral dyssynergia" means
The bladder has two main muscles for voiding:
- The detrusor — the muscle that squeezes the bladder to push urine out
- The urethral sphincter — the muscle that opens to let urine pass
In normal voiding, these coordinate — the sphincter opens as the detrusor contracts. In dyssynergia, they don't coordinate properly. This is the most characteristic urologic finding in Alström.²
Symptoms
The severity ranges:
Minor symptoms
- Decreased bladder sensation — long intervals between urination
- Urgency with sudden need to void
- Hesitancy — difficulty starting urination
- Slow or weak urinary stream
Moderate symptoms
- Frequency — needing to void often
- Incontinence — leaking urine
- Recurrent urinary tract infections
More severe (less than 2% of patients)
- Severe incontinence
- Urinary retention — inability to fully empty the bladder
- Complications from obstruction
When symptoms emerge
Urologic problems in Alström tend to emerge:
- More commonly in females
- Often in late teens or adulthood
- Sometimes alongside hormonal changes or pregnancy
Diagnosis
A urologic evaluation typically includes:
- Detailed history of urinary symptoms
- Physical examination
- Urinalysis to rule out infection
- Urodynamic studies — measure bladder filling and emptying patterns
- Bladder ultrasound — measures bladder wall thickness and post-void residual
- Cystoscopy in some cases — visualization of the bladder and urethra³
Treatment
Behavioral approaches
- Timed voiding — voiding on a schedule rather than waiting for the urge
- Pelvic floor physical therapy — can help coordination
- Fluid timing — avoiding large fluid intakes near events or bedtime
- Bladder training
Medications
- Alpha-blockers (tamsulosin, alfuzosin) — relax the sphincter, helping coordination
- Anticholinergics (oxybutynin, solifenacin) — reduce overactive bladder symptoms in selected patients
- Onabotulinumtoxin A (Botox) — for refractory overactive bladder
Catheterization
For patients with significant retention, intermittent self-catheterization several times a day allows complete bladder emptying. This is well-tolerated by most patients and prevents complications.
Surgical options
For specific anatomical issues, various surgical procedures may be options — uncommon in routine Alström urologic care.
Preventing complications
Untreated voiding dysfunction can lead to:
- Recurrent urinary tract infections
- Kidney damage from chronic obstruction
- Bladder thickening and reduced capacity
- Quality of life impacts
Recognition and treatment prevent most of these.
Common questions
Frequently asked questions
Short answers grounded in the article and the underlying references, so families can quickly understand the main point without losing the medical meaning.
Question
Are bladder issues universal in Alström?
Answer
About half of patients have some urologic issue. Severity varies widely. Many have mild symptoms; a smaller subset has significant problems.
Question
Should we screen for bladder issues?
Answer
Reasonable to ask about urinary symptoms at routine visits, particularly in adolescent and adult women. Specific urologic evaluation is appropriate when symptoms suggest a problem.
Question
Can these issues be reversed?
Answer
The underlying dysfunction often persists, but symptoms can typically be well-managed with the approaches above. Many patients live well with their urologic issues stably managed.
Question
Will my child need a urologist?
Answer
Many patients benefit from a urologist familiar with neuromuscular bladder issues, particularly as adolescent and adult symptoms emerge. Pediatric urology can address symptoms in younger children when present.